Sign in to continue:

Wednesday, April 8th, 2026

American Healthcare REIT, Inc. Signs Second Amendment to Credit Agreement – Signed by CFO Brian S. Peay




American Healthcare REIT, Inc. (AHR) – Detailed Investor Update on Material Definitive Agreement

American Healthcare REIT, Inc. (AHR) Announces Second Amendment to Credit Agreement

Key Points from the Report

  • Filing Date: April 7, 2026
  • Date of Reported Event: April 1, 2026
  • Nature of Filing: 8-K Current Report regarding entry into a Material Definitive Agreement and creation of a Direct Financial Obligation.
  • Instrument Impacted: Second Amendment to the Second Amended and Restated Credit Agreement
  • Parties Involved: American Healthcare REIT, Inc. and its subsidiaries, including several Delaware LLCs and partnerships, and a syndicate of major financial institutions led by Wells Fargo Bank, N.A.
  • Trading Symbol: AHR (listed on NYSE)
  • Signatories: The agreement is executed by Brian S. Peay, Chief Financial Officer, on behalf of American Healthcare REIT, Inc. and its subsidiaries.

Detailed Description of the Material Definitive Agreement

On April 1, 2026, American Healthcare REIT, Inc. (“AHR” or “the Company”) entered into the Second Amendment to the Second Amended and Restated Credit Agreement with Wells Fargo Bank, N.A. as the administrative agent, and a syndicate of other lenders. This amendment modifies the terms of the Company’s primary credit facility, which is a significant source of liquidity and financial flexibility for AHR.

The amendment includes various changes to the credit agreement, including updated representations, warranties, and covenants. The legal structure for the amendment is highly detailed, with multiple entities within the AHR corporate family acting as borrowers or guarantors. These include American Healthcare REIT Holdings, LP, various Delaware limited liability companies (such as GAHC3 Delta Valley ALF Portfolio, LLC; GAHC3 East Texas MOB Portfolio, LLC; GAHC3 Independence MOB Portfolio, LLC, among others), and the agreements are signed on behalf of all relevant entities.

The amendment process involves the removal and addition of specific provisions, with stricken text and double-underlined new text. The document clarifies that any references to the “Credit Agreement” in other corporate documents should now be considered as referring to the newly amended agreement.

A key condition for the effectiveness of the new amendment is the delivery and certification of updated organizational documents for each credit party. This ensures that each entity’s legal existence and structure complies with the requirements set by the lenders and administrative agent. The Company has confirmed that these documents are true and correct, certified by appropriate officers, and up to date as required.

Notably, the amendment also updates the reference points for financial statement delivery and compliance. All required financial statements and compliance certificates provided under the Credit Agreement must now refer to the most recently delivered statements under the relevant sections of the agreement.

Potential Impact and Price-Sensitive Information for Shareholders

  • Direct Financial Obligation: The execution of this amendment creates or modifies direct financial obligations for AHR and its subsidiaries. The credit facility is central to AHR’s capital structure and liquidity. Any changes to its terms, covenants, or availability can have a material impact on the Company’s financial flexibility, risk profile, and its ability to pursue strategic initiatives or manage debt maturities.
  • Ongoing Access to Credit: By maintaining and amending its syndicated credit facility, AHR signals ongoing access to institutional financing, which is critical for ongoing operations, acquisitions, and balance sheet management.
  • Comprehensive Subsidiary Involvement: The fact that numerous subsidiaries are included as borrowers or guarantors may indicate the breadth of collateral and guarantees supporting the credit facility, which could impact leverage, liquidity, and future borrowing capacity.
  • Price Sensitivity: While the amendment itself does not disclose new financial terms such as interest rates, covenant levels, or changes in facility size, the execution and effectiveness of a major credit agreement amendment is typically viewed as a positive for credit and liquidity outlook. Any subsequent disclosures regarding the financial terms could further impact share value.
  • Leadership Sign-off: The agreement is executed at the highest financial level (by the CFO, Brian S. Peay), indicating board-level oversight and the strategic importance of the credit facility.

What Shareholders Need to Know

  • Material Agreement: The amendment is a “material definitive agreement” under SEC rules—meaning it is significant enough to potentially affect the Company’s share price or investment profile.
  • Liquidity Position: The continued ability to amend and extend its credit agreements with major financial institutions is a positive signal about AHR’s relationships with lenders and underlying creditworthiness.
  • Disclosure Compliance: AHR is in compliance with required financial reporting and disclosure obligations as set out in the amended agreement, with all parties providing the necessary certifications and supporting documents.
  • No Emerging Growth Company Election: The Company has not elected emerging growth company status, nor has it elected any extended transition period for new accounting standards, which can be relevant for institutional investors.

Conclusion

In summary, the Second Amendment to the Second Amended and Restated Credit Agreement is a material development for American Healthcare REIT, Inc. It secures ongoing financing, demonstrates lender confidence, and ensures continued liquidity and operational flexibility for the Company and its numerous subsidiaries. Shareholders should monitor future disclosures related to the specific financial terms and any additional amendments, as these could have further implications for valuation, leverage, and risk profile.


Disclaimer: This article is for informational purposes only and should not be considered investment advice. Investors should consult with their financial advisors and review the full SEC filings before making any investment decisions. The information is based on current filings and may be subject to change or update without notice.




View American Healthcare REIT, Inc. Historical chart here



   Ad